Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy

NCT: NCT05318027 · ACTIVE_NOT_RECRUITING

NCT IDNCT05318027
StatusACTIVE_NOT_RECRUITING
Start Date2023-05-22
Completion2026-12

Brief Summary

Evaluate the feasibility of using a chatbot combined with continuous activity monitoring to proactively identify, appropriately triage and help manage patients' symptoms during cancer treatment Determine whether such an early outpatient clinic-based intervention can decrease rates of excess triage visits Correlate changes in activity and early symptom management to emergency department visits, unplanned inpatient hospitalizations and treatment breaks

Frequently Asked Questions

What is ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy?

ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy is a clinical trial registered under NCT05318027. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05318027?

The current status of NCT05318027 (ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy) is: ACTIVE_NOT_RECRUITING.

When did ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy start?

ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy started on 2023-05-22.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.